Cargando…

Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19

The type 2 coronavirus causes severe acute respiratory syndrome (SARS-CoV-2) and produces pneumonia with pulmonary alveolar collapse. In some cases it also causes sepsis and septic shock. There is no specific treatment for coronavirus disease 2019 (COVID-19). Vitamin C (Vit C), Vitamin E (Vit E), N-...

Descripción completa

Detalles Bibliográficos
Autores principales: Chavarría, Adrián Palacios, Vázquez, Rafael Ricardo Valdez, Cherit, José Guillermo Domínguez, Bello, Héctor Herrera, Suastegui, Humberto Castillejos, Moreno-Castañeda, Lidia, Alanís Estrada, Gabriela, Hernández, Fabián, González-Marcos, Omar, Saucedo-Orozco, Huitzilihuitl, Manzano-Pech, Linaloe, Márquez-Velasco, Ricardo, Guarner-Lans, Verónica, Pérez-Torres, Israel, Soto, Maria Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910139/
https://www.ncbi.nlm.nih.gov/pubmed/33680348
http://dx.doi.org/10.1016/j.csbj.2021.02.009
_version_ 1783656068635688960
author Chavarría, Adrián Palacios
Vázquez, Rafael Ricardo Valdez
Cherit, José Guillermo Domínguez
Bello, Héctor Herrera
Suastegui, Humberto Castillejos
Moreno-Castañeda, Lidia
Alanís Estrada, Gabriela
Hernández, Fabián
González-Marcos, Omar
Saucedo-Orozco, Huitzilihuitl
Manzano-Pech, Linaloe
Márquez-Velasco, Ricardo
Guarner-Lans, Verónica
Pérez-Torres, Israel
Soto, Maria Elena
author_facet Chavarría, Adrián Palacios
Vázquez, Rafael Ricardo Valdez
Cherit, José Guillermo Domínguez
Bello, Héctor Herrera
Suastegui, Humberto Castillejos
Moreno-Castañeda, Lidia
Alanís Estrada, Gabriela
Hernández, Fabián
González-Marcos, Omar
Saucedo-Orozco, Huitzilihuitl
Manzano-Pech, Linaloe
Márquez-Velasco, Ricardo
Guarner-Lans, Verónica
Pérez-Torres, Israel
Soto, Maria Elena
author_sort Chavarría, Adrián Palacios
collection PubMed
description The type 2 coronavirus causes severe acute respiratory syndrome (SARS-CoV-2) and produces pneumonia with pulmonary alveolar collapse. In some cases it also causes sepsis and septic shock. There is no specific treatment for coronavirus disease 2019 (COVID-19). Vitamin C (Vit C), Vitamin E (Vit E), N-acetylcysteine (NAC) and Melatonin (MT) increase the intracellular content of GSH, kidnap free radicals and protect DNA, proteins in the cytosol and lipids in cell membranes. Pentoxifylline (Px) has anti-inflammatory activities. Here we evaluate the effect of Vit C, Vit E, NAC, and MT plus Px in COVID-19 patients with moderate and severe pneumonia. 110 patients of either sex were included. They were divided into five groups with 22 patients each. Group 1 received Vit C + Px, group 2 Vit E + Px, group 3 NAC + Px, group 4 MT + Px, and group 5 only Px. Oxidative stress (OS) markers such as lipid peroxidation (LPO) levels, total antioxidant capacity (TAC) and nitrites (NO(2)(–)) were evaluated in plasma. The antioxidant therapy improved the survival scores including the Sequential Organ Failure Assessment (SOFA), the Acute Physiology and chronic Health Evaluation II (Apache II), the Simplified Acute Physiology Score II (SAPS II), the Critical Illness Risk Score, Launched during COVID-19 crisis (COVIDGRAM) and the Glasgow Coma Scale (GCS). We found that LPO (p≤0.04) and inflammation markers such as interleukin-6 (IL-6, p≤ 0.01), C reactive protein (CRP, p ≤ 0.01) and procalcitonin (PCT, p ≤ 0.05) were elevated. TAC (p ≤ 0.03) and NO(2)(–) (p ≤ 0.04) found themselves diminished in diminished in COVID-19 patients upon admission to the hospital. The different antioxidants reversed this alteration at the end of the treatment. The treatment with antioxidant supplements such as Vit C, E, NAC, and MT plus Px could decelerate the aggressive and lethal development of COVID-19. Antioxidant therapy can be effective in this pandemia since it improves the survival scores including SOFA, Apache II, SAPS II, COVIDGRAM, GCS by lowering the LPO, IL-6, CRP, PCT and increasing systemic TAC and NO(2)(–).
format Online
Article
Text
id pubmed-7910139
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Research Network of Computational and Structural Biotechnology
record_format MEDLINE/PubMed
spelling pubmed-79101392021-03-01 Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19 Chavarría, Adrián Palacios Vázquez, Rafael Ricardo Valdez Cherit, José Guillermo Domínguez Bello, Héctor Herrera Suastegui, Humberto Castillejos Moreno-Castañeda, Lidia Alanís Estrada, Gabriela Hernández, Fabián González-Marcos, Omar Saucedo-Orozco, Huitzilihuitl Manzano-Pech, Linaloe Márquez-Velasco, Ricardo Guarner-Lans, Verónica Pérez-Torres, Israel Soto, Maria Elena Comput Struct Biotechnol J Research Article The type 2 coronavirus causes severe acute respiratory syndrome (SARS-CoV-2) and produces pneumonia with pulmonary alveolar collapse. In some cases it also causes sepsis and septic shock. There is no specific treatment for coronavirus disease 2019 (COVID-19). Vitamin C (Vit C), Vitamin E (Vit E), N-acetylcysteine (NAC) and Melatonin (MT) increase the intracellular content of GSH, kidnap free radicals and protect DNA, proteins in the cytosol and lipids in cell membranes. Pentoxifylline (Px) has anti-inflammatory activities. Here we evaluate the effect of Vit C, Vit E, NAC, and MT plus Px in COVID-19 patients with moderate and severe pneumonia. 110 patients of either sex were included. They were divided into five groups with 22 patients each. Group 1 received Vit C + Px, group 2 Vit E + Px, group 3 NAC + Px, group 4 MT + Px, and group 5 only Px. Oxidative stress (OS) markers such as lipid peroxidation (LPO) levels, total antioxidant capacity (TAC) and nitrites (NO(2)(–)) were evaluated in plasma. The antioxidant therapy improved the survival scores including the Sequential Organ Failure Assessment (SOFA), the Acute Physiology and chronic Health Evaluation II (Apache II), the Simplified Acute Physiology Score II (SAPS II), the Critical Illness Risk Score, Launched during COVID-19 crisis (COVIDGRAM) and the Glasgow Coma Scale (GCS). We found that LPO (p≤0.04) and inflammation markers such as interleukin-6 (IL-6, p≤ 0.01), C reactive protein (CRP, p ≤ 0.01) and procalcitonin (PCT, p ≤ 0.05) were elevated. TAC (p ≤ 0.03) and NO(2)(–) (p ≤ 0.04) found themselves diminished in diminished in COVID-19 patients upon admission to the hospital. The different antioxidants reversed this alteration at the end of the treatment. The treatment with antioxidant supplements such as Vit C, E, NAC, and MT plus Px could decelerate the aggressive and lethal development of COVID-19. Antioxidant therapy can be effective in this pandemia since it improves the survival scores including SOFA, Apache II, SAPS II, COVIDGRAM, GCS by lowering the LPO, IL-6, CRP, PCT and increasing systemic TAC and NO(2)(–). Research Network of Computational and Structural Biotechnology 2021-02-27 /pmc/articles/PMC7910139/ /pubmed/33680348 http://dx.doi.org/10.1016/j.csbj.2021.02.009 Text en © 2021 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Chavarría, Adrián Palacios
Vázquez, Rafael Ricardo Valdez
Cherit, José Guillermo Domínguez
Bello, Héctor Herrera
Suastegui, Humberto Castillejos
Moreno-Castañeda, Lidia
Alanís Estrada, Gabriela
Hernández, Fabián
González-Marcos, Omar
Saucedo-Orozco, Huitzilihuitl
Manzano-Pech, Linaloe
Márquez-Velasco, Ricardo
Guarner-Lans, Verónica
Pérez-Torres, Israel
Soto, Maria Elena
Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19
title Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19
title_full Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19
title_fullStr Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19
title_full_unstemmed Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19
title_short Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19
title_sort antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by covid-19
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910139/
https://www.ncbi.nlm.nih.gov/pubmed/33680348
http://dx.doi.org/10.1016/j.csbj.2021.02.009
work_keys_str_mv AT chavarriaadrianpalacios antioxidantsandpentoxifyllineascoadjuvantmeasurestostandardtherapytoimproveprognosisofpatientswithpneumoniabycovid19
AT vazquezrafaelricardovaldez antioxidantsandpentoxifyllineascoadjuvantmeasurestostandardtherapytoimproveprognosisofpatientswithpneumoniabycovid19
AT cheritjoseguillermodominguez antioxidantsandpentoxifyllineascoadjuvantmeasurestostandardtherapytoimproveprognosisofpatientswithpneumoniabycovid19
AT bellohectorherrera antioxidantsandpentoxifyllineascoadjuvantmeasurestostandardtherapytoimproveprognosisofpatientswithpneumoniabycovid19
AT suasteguihumbertocastillejos antioxidantsandpentoxifyllineascoadjuvantmeasurestostandardtherapytoimproveprognosisofpatientswithpneumoniabycovid19
AT morenocastanedalidia antioxidantsandpentoxifyllineascoadjuvantmeasurestostandardtherapytoimproveprognosisofpatientswithpneumoniabycovid19
AT alanisestradagabriela antioxidantsandpentoxifyllineascoadjuvantmeasurestostandardtherapytoimproveprognosisofpatientswithpneumoniabycovid19
AT hernandezfabian antioxidantsandpentoxifyllineascoadjuvantmeasurestostandardtherapytoimproveprognosisofpatientswithpneumoniabycovid19
AT gonzalezmarcosomar antioxidantsandpentoxifyllineascoadjuvantmeasurestostandardtherapytoimproveprognosisofpatientswithpneumoniabycovid19
AT saucedoorozcohuitzilihuitl antioxidantsandpentoxifyllineascoadjuvantmeasurestostandardtherapytoimproveprognosisofpatientswithpneumoniabycovid19
AT manzanopechlinaloe antioxidantsandpentoxifyllineascoadjuvantmeasurestostandardtherapytoimproveprognosisofpatientswithpneumoniabycovid19
AT marquezvelascoricardo antioxidantsandpentoxifyllineascoadjuvantmeasurestostandardtherapytoimproveprognosisofpatientswithpneumoniabycovid19
AT guarnerlansveronica antioxidantsandpentoxifyllineascoadjuvantmeasurestostandardtherapytoimproveprognosisofpatientswithpneumoniabycovid19
AT pereztorresisrael antioxidantsandpentoxifyllineascoadjuvantmeasurestostandardtherapytoimproveprognosisofpatientswithpneumoniabycovid19
AT sotomariaelena antioxidantsandpentoxifyllineascoadjuvantmeasurestostandardtherapytoimproveprognosisofpatientswithpneumoniabycovid19